We read with great interest the recent article by Dr. Kurth et al 1 dealing with the relationship between smoking and hemorrhagic stroke in women. The results of their prospective study demonstrated that the risk of total hemorrhagic stroke, such as intracerebral hemorrhage and subarachnoid hemorrhage, was increased in women who are current cigarette smokers. The authors proposed that smoking may cause structural damage to the arterial wall and be a risk factor for both ischemic and hemorrhagic stroke in women.
Response
Tsuada and Nishio postulate a potential beneficial effect of estradiol on the arterial wall, although the effect of estradiol on the vascular system in the brain remains controversial. 1 In addition, recent randomized trial data provided evidence that postmenopausal hormone therapy increases the risk of ischemic stroke. 2 Plasma estradiol levels were only measured in a small case-control study 3 from participants of the Women's Health Study. Preliminary results did not show statistically significant differences of plasma estradiol levels according to smoking status among users and non-users of postmenopausal hormone therapy. With respect to exogenous hormones, we showed that current smokers were less likely to utilize postmenopausal hormone therapy (see Table 1 in Reference 4). In our data, although based on a small number of cases, postmenopausal hormone use did not significantly modify the association between smoking and total hemorrhagic stroke.
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